PM360

APRIL 25, 2023

Y will talk about the most recent clinical trial data for a study that they’ve been following or Dr. B will be at a major conference and talk about the best places to get food nearby. But in terms of length, a pizza review might take 12 seconds, but talking about the most recent clinical trial data might take 27.

Physicians 97

Physicians Media Marketing Recruitment 97

World of DTC Marketing

MARCH 23, 2022

The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012. Patients trust their doctors, so the accelerated approval process must be modified to increase their trust with physicians and explain to patients precisely what accelerated drug approval means. Do patients care?

Patients 200

Patients FDA Doctors Physicians 200

World of DTC Marketing

FEBRUARY 10, 2022

It isn’t real food; it is the packaged, highly refined, chemically-laden products marketed to us as “food” that is killing us and will continue to do so until we reframe what is being perpetrated on consumers in terms of addiction. . But what is it we are eating? So how do we respond?

Insurance 197

Insurance Government Food Consulting 197

World of DTC Marketing

JULY 17, 2022

Unpaid celebrity endorsements include venture capitalist Marc Andreessen, who says the drug completely changed his relationship with food, and Elon Musk, who has cited it on Twitter. Lamanna anticipates it could take two to three years to change the minds of primary care physicians. So far, the data for Wegovy looks excellent.

Side effects 209

Side effects Doctors Insurance Prescription 209

Legacy MEDSearch

OCTOBER 18, 2023

Food and Drug Administration (FDA) 510(k) clearance for the company’s FreedomFlow Orbital Atherectomy Peripheral Platform. It also provides faster run times, consistent treatment outcomes, and a nearly flat learning curve for physicians, making it an ideal choice for today’s hospitals, ambulatory surgical centers, and office-based labs.

Food and Drug Administration 52

Food and Drug Administration Food FDA Physicians 52

World of DTC Marketing

NOVEMBER 3, 2020

In times of stress too many people turn to bad foods as an outlet. Physicians should be required to tell unhealthy patients that they are in danger of getting serious health problems that could sideline them from work and family for a long time. Our healthcare system is set up to treat patients not to prevent bad health habits.

Insurance 190

Insurance Healthcare Healthcare Physicians 190

World of DTC Marketing

JULY 5, 2022

While the population is more worried about COVID, they are killing themselves by overeating processed food and not getting any exercise. The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise. Why don’t doctors have the “the talk”?

Insurance 200

Insurance Doctors Pharma Side effects 200

World of DTC Marketing

JUNE 6, 2022

There are many risk factors for type 2 diabetes, but one of the biggest is a poor diet high in processed foods and added sugar. They’re closely related—many processed foods quickly break down into sugar. When the body is swamped with sugar, it can become resistant to insulin.

Healthcare 174

Healthcare Healthcare Food Government 174

Legacy MEDSearch

SEPTEMBER 12, 2022

a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, announced U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of a next-generation RhinAer® stylus. Aerin Medical Inc., Aerin Medical is a privately held, venture-backed company, with U.S.

Medical 98

Medical Patients FDA Physicians 98

Nixon Gwilt Law

JULY 12, 2024

The 2025 Medicare Physician Fee Schedule Proposed Rule (the “2025 Proposed Rule”) issued by the Centers for Medicare and Medicaid Services (or “CMS”) on July 10, 2024 contains a number of new policy proposals with significant implications for healthcare innovators. Stakeholders should consider submitting comments on this issue.

Physicians 52

Physicians Management Food and Drug Administration Healthcare 52

Pharmaceutical Technology

AUGUST 12, 2022

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses.

Food and Drug Administration 141

Food and Drug Administration Pharmacology Side effects Physicians 141

Clarify Health

FEBRUARY 13, 2023

When I was a practicing physician, I worked at a Medicaid clinic. For example, I know of an ER physician who said that parents would bring their children to see her because their children had abdominal pain. Can you share an example of how a value-based care model can address barriers to patients receiving care?

Physicians 52

Physicians Patients Prescription Doctors 52

Nixon Gwilt Law

NOVEMBER 30, 2023

Reimbursement for Community Health Integration, Social Determinants Risk Assessment, and Principal Illness Navigation On November 2, the Centers for Medicare and Medicaid Services (“CMS”) released the 2024 Medicare Physician Fee Schedule (“2024 MPFS”) final rule.

Physicians 52

Physicians Patients Training Management 52

Nixon Gwilt Law

NOVEMBER 30, 2023

Reimbursement for Community Health Integration, Social Determinants Risk Assessment, and Principal Illness Navigation On November 2, the Centers for Medicare and Medicaid Services (“CMS”) released the 2024 Medicare Physician Fee Schedule (“2024 MPFS”) final rule.

Physicians 52

Physicians Patients Management Training 52

Evolve Your Success

SEPTEMBER 11, 2024

The episode delves into the challenges of market awareness and the positive impact Hex IQ’s solutions have had on medical sales reps and physicians alike. We explore her background, the pivotal moment that led to Hex IQ’s creation, and the competitive edge the company offers in making healthcare data transparent and actionable.

Sales 130

Sales Medical sales reps Medical sales Healthcare 130

European Pharmaceutical Review

JANUARY 19, 2023

The contribution will enable the programme to reach additional physicians and medical students, further expanding the initiative that aims to extend the reach of clinical trials in underserved patient populations in US communities. The Winn Award Program has so far trained 114 early-stage investigator physicians.

Food and Drug Administration 98

Food and Drug Administration Physicians Medicine Food 98

European Pharmaceutical Review

MARCH 18, 2024

Gardner Family Center for Parkinson’s Disease Research Endowed Chair in UC’s Department of Neurology and Rehabilitation Medicine and a physician at the UC Gardner Neuroscience Institute explained. and Joan A. He noted that this means the treatment dose needs to be increased or administered more often.

Food and Drug Administration 98

Food and Drug Administration Medicine Physicians Food 98

Pharmaceutical Technology

MAY 29, 2023

Lexicon Pharmaceuticals (Lexicon) has received approval from the US Food and Drug Administration (FDA) for its Inpefa drug to treat heart failure. Inpefa is a once-daily oral tablet indicated as an inhibitor of sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1).

Food and Drug Administration 98

Food and Drug Administration FDA Transportation Physicians 98

Pharmaceutical Technology

FEBRUARY 5, 2023

The US Food and Drug Administration (FDA) has granted approval for Gilead Sciences ’ Trodelvy (sacituzumab govitecan-hziy) to treat unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+ or IHC 2+/ISH–) breast cancer adult patients.

Food and Drug Administration 105

Food and Drug Administration FDA Physicians Food 105

Pharmaceutical Technology

FEBRUARY 20, 2023

The US Food and Drug Administration (FDA) has granted approval for Apellis Pharmaceuticals’ Syfovre (pegcetacoplan injection) to treat geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD). Syfovre is claimed to be the first and only therapy approved for GA.

Food and Drug Administration 98

Food and Drug Administration FDA Physicians Food 98

Pharmaceutical Technology

JULY 20, 2022

On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Food and Drug Administration 111

Food and Drug Administration Physicians Medical Prescription 111

European Pharmaceutical Review

APRIL 8, 2024

The first BCMA-targeted CAR-T cell therapy for second-line treatment of multiple myeloma has been approved by the US Food and Drug Administration (FDA). When the cilta-cel CAR protein binds to BCMA-expressing cells, the CAR promotes T-cell activation, expansion, and elimination of target cells, Legend Biotech explained.

Food and Drug Administration 98

Food and Drug Administration FDA Medicine Physicians 98

Evolve Your Success

FEBRUARY 28, 2023

We’re assisting the physicians in all of these cardiac procedures, which at that time, was blowing up because we were going from cutting someone’s chest open to do bypass surgery to angioplasty, and all these new techniques. I got a chance to become a clinical specialist and work with physicians rolling out this new technology.

Sales 227

Sales Medical sales Medical Physicians 227

pharmaphorum

DECEMBER 4, 2022

The device has been tested in animals so far, and last year Neuralink unveiled a pig called Gertrude which had a chip implanted that allowed neural activity in her snout to be transmitted and recorded as she rooted for food. — Physicians Committee (@PCRM) November 30, 2022. Take action! link] (12/12).

Side effects 118

Side effects Recruitment Physicians Food 118

European Pharmaceutical Review

OCTOBER 25, 2022

The US Food and Drug Administration’s (FDA) approval took data from the HIMALAYA Phase III trial into consideration. Phase III trial results found that three years post-treatment, 31 percent of patients given the drug combination were still alive. The statistic for those just offered sorafenib was 20 percent.

Food and Drug Administration 111

Food and Drug Administration Patients Safety Physicians 111

European Pharmaceutical Review

MAY 23, 2024

Last month, CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) was the first BCMA-targeted CAR-T cell therapy to be approved for second-line treatment of multiple myeloma by the US Food and Drug Administration (FDA). How has the autologous T-cell immunotherapy field progressed in recent years?

Food and Drug Administration 110

Food and Drug Administration Food Medical Medicine 110

Legacy MEDSearch

NOVEMBER 9, 2022

Food and Drug Administration. The adoption of the Early Bird system is a testimony to physicians embracing the benefits of early bleed detection for their patients and practice.”. “We The Early Bird was launched in 2019 following a De Novo classification by the U.S. For more information, please visit www.saranas.com.

Patients 98

Patients Food and Drug Administration Physicians Recruitment 98

European Pharmaceutical Review

DECEMBER 6, 2023

The US Food and Drug Administration (FDA) has approved the first oral monotherapy treatment for adults with paroxysmal nocturnal haemoglobinuria (PNH). Novartis’ Factor B inhibitor, Fabhalta ® (iptacopan) provides comprehensive control of red blood cell (RBC) destruction, according to the company. percent for anti-C5.

Food and Drug Administration 108

Food and Drug Administration Patients Physicians Food 108

Pharma Marketing Network

MARCH 3, 2021

Although the number of in-person patients visits increased across all specialties post-lockdown, in May 2020, they were still down by 20% compared with pre-COVID-19 times, and 46% of physicians believed at the time that remote visits would continue in the long term. This likely is still the case as we move into 2021.

Patients 88

Patients Physicians Pharma Insurance 88

Nixon Gwilt Law

AUGUST 9, 2023

In the proposed 2024 Medicare Physician Fee Schedule (MPFS), the Centers for Medicare and Medicaid Services (CMS) proposes new CPT codes to facilitate reimbursement for healthcare providers who help patients overcome social and environmental health barriers. One of the greatest challenges facing the U.S. CMS defines SDOH as: “.including

Patients 89

Patients Physicians Management Transportation 89

Legacy MEDSearch

MARCH 1, 2023

a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today announced Food and Drug Administration (FDA) 510(k) clearance of their flagship intravascular imaging system, HyperVue. SpectraWAVE, Inc., Chief Executive Officer of SpectraWAVE.

Food and Drug Administration 97

Food and Drug Administration Physicians Recruitment Medical 97

Clarify Health

AUGUST 1, 2022

She’s a physician by training and now specializes in driving Clarify’s product strategy and roadmap to enhance clinical nuance, improve actionability and ensure the most impactful use of social determinants of health (SDoH) insights. Read our Q&A below, where we discuss health equity, battling physician bias and more.

Healthcare 98

Healthcare Healthcare Physicians Training 98

Pharmaceutical Technology

APRIL 4, 2023

Vertex Pharmaceuticals and CRISPR Therapeutics have completed the rolling submission of biologics licence applications (BLAs) to the US Food and Drug Administration (FDA) for exagamglogene autotemcel (exa-cel) to treat sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).

Food and Drug Administration 98

Food and Drug Administration FDA Medicine Pharmaceutical 98

Clarivate

APRIL 24, 2023

CVS then began affiliating with health systems across the country (like Cleveland Clinic ) for physician oversight of MinuteClinic’s staffed midlevel providers, just as Walgreens was rising as a formidable competitor in the convenient care space through its own walk-in clinics that it launched in fall 2006. Key acquisitions by U.S.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

pharmaphorum

SEPTEMBER 29, 2022

Food and Drug Administration (FDA) regulation as a medical device. Kyle advises investors, academic medical centres, physician practices, and consultants on a range of business, legal, and regulatory issues affecting the telemedicine industry. If so, developers must develop and execute on a regulatory strategy.

Food and Drug Administration 104

Food and Drug Administration FDA Medical Food 104

Legacy MEDSearch

MARCH 15, 2023

In February 2022, HeartBeam partnered with LIVMOR to build a HeartBeam-branded version of LIVMOR’s FDA-cleared Halo cloud-based software platform to connect physicians and patients. HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA or other geographies.

Food and Drug Administration 97

Food and Drug Administration FDA Recruitment Physicians 97

Pharmaceutical Technology

AUGUST 8, 2022

The US Food and Drug Administration (FDA) has granted approval for Pfizer and Myovant Sciences ’ Myfembree (relugolix 40mg, estradiol 1mg and norethindrone acetate 0.5mg) to manage moderate-to-severe pain linked with endometriosis in pre-menopausal women.

Food and Drug Administration 75

Food and Drug Administration FDA Management Physicians 75